RefleXion Medical is a privately held medical device company developing the first biology-guided radiotherapy (BgRT) system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize radiotherapy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/19/16 | $52,000,000 | Series B |
Johnson & Johnson Innovation KCK Group Pfizer Venture Investments Venrock | undisclosed |
| 04/05/18 | $100,000,000 | Series C |
GT Healthcare Capital Partners Johnson & Johnson Innovation KCK Group Pfizer Venture Investments Sofinnova Partners T. Rowe Price The Rise Fund  Venrock | undisclosed |
| 04/16/20 | $100,000,000 | Venture |
Johnson & Johnson Innovation KCK Group Pfizer Venture Investments PSP Investments Sofinnova Partners T. Rowe Price The Rise Fund Venrock | undisclosed |
